Analogs 2-5 of balanol (-)-1, a potent protein kinase C (PKC) inhibitor, were prepared in which the perhydroazepine N atom was replaced with O, S, or C. Compounds 2 and 3 are found to show enhanced isozyme selectivity, despite the general trend of these analogs being less potent PKC inhibitors relative to balanol.